EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 2

Ensembl ID : ENSODEG00000004014
Gene Symbol: KCNQ2
3 Cross references
248 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 3

Ensembl ID : ENSODEG00000000541
Gene Symbol: KCNQ3
3 Cross references
191 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSODEG00000004476
Gene Symbol: KCNQ5
1 Cross references
278 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSODEG00000016888
Gene Symbol: PSEN1
3 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSODEG00000013898
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSODEG00000015490
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSODEG00000012057
Gene Symbol: PTGDR
3 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSODEG00000010144
Gene Symbol: PTGER1
3 Cross references
235 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSODEG00000011973
Gene Symbol: PTGER2
3 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSODEG00000005473
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSODEG00000003031
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSODEG00000003205
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).